First Allied Advisory Services’s Global Blood Therapeutics, Inc. GBT Stock Holding History

First Allied Advisory Services’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$480K	Sell	8,700 -3,600	-29%	-$229K	0.02%	720
2020 Q2	$776K	Buy	12,300 +7,368	+149%	+$505K	0.03%	518
2020 Q1	$252K	Buy	4,932 +432	+10%	+$28.9K	0.01%	833
2019 Q4	$358K	Buy	+4,500	New	+$267K	0.01%	846
2019 Q2	–	Sell	-3,950	Closed	-$208K	–	1256
2019 Q1	$208K	Sell	3,950 -1,200	-23%	-$59K	0.01%	1037
2018 Q4	$211K	Sell	5,150 -4,600	-47%	-$172K	0.01%	935
2018 Q3	$371K	Buy	9,750 +1,800	+23%	+$79.7K	0.01%	820
2018 Q2	$359K	Buy	7,950 +1,400	+21%	+$63.7K	0.01%	809
2018 Q1	$317K	Sell	6,550 -775	-11%	-$43.2K	0.01%	845
2017 Q4	$288K	Buy	+7,325	New	+$274K	0.01%	895

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Allied Advisory Services's GBT Position: Q3 2020 in Review

First Allied Advisory Services reduced its Global Blood Therapeutics, Inc. (GBT) stake by 29% in Q3 2020, selling an estimated $229K and leaving 8,700 shares worth $480K. The position accounts for 0.02% of the portfolio, ranked #720.

First Allied Advisory Services first reported a position in GBT in Q4 2017 and has held it in 10 quarters since. The position peaked at $776K in Q2 2020. 229 funds tracked by Wall St. Rank hold GBT as of Q3 2020.

First Allied Advisory Services held 8,700 shares of Global Blood Therapeutics, Inc. worth $480K as of Q3 2020.
First Allied Advisory Services sold 3,600 Global Blood Therapeutics, Inc. shares in Q3 2020, an estimated $229K.
Global Blood Therapeutics, Inc. made up 0.02% of First Allied Advisory Services's portfolio in Q3 2020, its #720 holding.
First Allied Advisory Services first reported a position in Global Blood Therapeutics, Inc. in Q4 2017 and has held it in 10 quarters since.
First Allied Advisory Services's Global Blood Therapeutics, Inc. position peaked at $776K in Q2 2020.
229 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.